For example, fenofibrate, which activates fatty acid β-oxidation via PPARα activation and is used to treat cardiovascular disease, has been shown to protect against cartilage degradation and reduce inflammation in osteoarthritis as a drug with autophagic and senolytic activity [65]. This evidence concerns the gene PPARA and cardiovascular disorder.